
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy Study of Patient Preoperative Preps In-vivo
Details : Chlorhexidine Gluconate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 16, 2021
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sls Toothpaste
Therapeutic Area : Dental and Oral Health
Study Phase : Undisclosed
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sls Toothpaste is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Oral Mucosal Disorder.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 23, 2020
Lead Product(s) : Sls Toothpaste
Therapeutic Area : Dental and Oral Health
Highest Development Status : Undisclosed
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage Area
Details : Chlorhexidine Gluconate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 24, 2018
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference
Details : Tiotropium is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 04, 2017
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Simbec Research | 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers
Details : Tiotropium is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 11, 2017
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Simbec Research | 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
In Vivo Preoperative Skin Preparation Persistence Evaluation
Details : Chlorhexidine Gluconate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 16, 2017
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Tiotropium is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 16, 2017
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Quotient Sciences | 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Tiotropium is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 08, 2016
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Quotient Sciences | 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Quotient Sciences | 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Tiotropium is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 11, 2015
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Quotient Sciences | 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
In Vivo Patient Preoperative Skin Prep Persistence
Details : Chlorhexidine Gluconate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 19, 2015
Lead Product(s) : Chlorhexidine Gluconate
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
